6 completed, 2 unknown, 1 recruiting, 1 withdrawn. 3 Not applicable, 2 Phase 4, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 3 |
| Phase 4 | 2 | Unknown 1, Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
Follow Retinopathy, Diabetic: new trials by email Literature Review of Retinopathy, Diabetic trials Research Report on Retinopathy, Diabetic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of the New Generation Anti-diabetic Drugs on Diabetic Retinopathy Diabetes (DM), Retinopathy, Diabetic | Recruiting | Sara A Belal | 70 | 2025-08-01 | 2026-01-20 | |
| Comparison of 4 Methods of Eye Drops for Pupil Dilation in Diabetic Patients 1 drop of a 0.8% tropicamide + 5% phenylephrine combination, 1 drop of 0.5% tetracaine and 1 drop of a 0.8% tropicamide + 5% phenylephrine combination, 3 drops of a 0.8% tropicamide + 5% phenylephrine combination - Diabetes (DM), Retinopathy, Diabetic | Not applicable | Completed | Burapha University | 84 | 2024-11-04 | 2026-03-27 |
| The Effect of Pyridoxamine Supplementation on Microvascular Function in Type 2 Diabetes Pyridoxamine 300mg per day, Placebo 300mg placebo per day - Type 2 Diabetes, Microvascular Function | Not applicable | Completed | Maastricht University Medical Center | 40 | 2024-03-21 | 2026-04-27 |
| Evaluation of a Health Education Program for Type 2 Diabetes Patients health educational sessions in diabetic patients type 2. - Retinopathy, Diabetic | Not applicable | Completed | Association for Innovation and Biomedical Research on Light and Image | 27 | 2023-10-13 | 2024-07-31 |
| Diabetic Retinopathy Classification: ETDRS 7-fields vs Widefield Imaging (ClarusDR) Retinopathy, Diabetic | Completed | Association for Innovation and Biomedical Research on Light and Image | 81 | 2023-04-03 | 2024-11-27 | |
| Evaluation of the Retina in Patients With Non-proliferative Diabetic Retinopathy After Aflibercept Injection in the Eye Aflibercept Injection, Sham injection - Retinopathy, Diabetic | Phase 4 | Withdrawn | University of Rochester | 2021-02-01 | 2021-05-05 | |
| DEXTENZA VS. PREDNISOLONE ACETATE 1% Macular Edema With Diabetic Retinopathy After Cataract Surgery Prednisolone Acetate 1% Ophthalmic Suspension [PRED FORTE] - Retinopathy, Diabetic | Phase 4 | Unknown | Ophthalmic Consultants of the Capital Region | 30 | 2020-08-07 | 2020-08-11 |
| REWARD: Using the REtina as a Window To Detect Cardiac microvasculAR Dysfunction In Diabetes Mellitus Cardiac Assessments and Eye Assessments - Retinopathy, Diabetic, Diastolic Dysfunction | Unknown | National Heart Centre Singapore | 60 | 2018-02-20 | 2021-02-03 | |
| Assessment of Color Vision in Diabetic Patients lucentis - Retinopathy, Diabetic | Completed | Instituto de Olhos de Goiania | 30 | 2017-08-01 | 2017-11-17 | |
| A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema darapladib, placebo - Retinopathy, Diabetic | Phase 2 | Completed | GlaxoSmithKline | 54 | 2012-02-01 | 2016-11-21 |
Diabetic Retinopathy (10) · Diabetes Mellitus (2) · Diabetes Mellitus, Type 2 (1) · Diabetic Nephropathies (1) · Diabetic Neuropathies (1) · Dilatation, Pathologic (1) · Mydriasis (1)
Cardiovascular Diseases (10) · Diabetes Complications (10) · Diabetic Angiopathies (10) · Endocrine System Diseases (10) · Eye Diseases (10) · Retinal Diseases (10) · Vascular Diseases (10) · Diabetes Mellitus (8) · Glucose Metabolism Disorders (3) · Metabolic Diseases (3) · Nutritional and Metabolic Diseases (3) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1)
Pyridoxamine (1) · Ranibizumab (1) · Tetracaine (1) · Tropicamide (1) · aflibercept (1) · darapladib (1) · prednisolone acetate (1) · salicylhydroxamic acid (1)
Association for Innovation and Biomedical Research on Light and Image (2) · Burapha University (1) · GlaxoSmithKline (1) · Instituto de Olhos de Goiania (1) · Maastricht University Medical Center (1) · National Heart Centre Singapore (1) · Ophthalmic Consultants of the Capital Region (1) · Sara A Belal (1) · University of Rochester (1)
Netherlands (2) · Portugal (2) · United States (2) · Australia (1) · Brazil (1) · Denmark (1) · Egypt (1) · Germany (1) · Italy (1) · Singapore (1) · Thailand (1)
Ana R Santos, PhD (1) · Nattawat Asawaworarit, M.D. (1) · Robert Feldman, MD (1)